Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections

被引:29
|
作者
Elhassan, Eman [1 ]
Devnarain, Nikita [1 ]
Mohammed, Mahir [1 ,3 ]
Govender, Thirumala [1 ]
Omolo, Calvin A. [1 ,2 ]
机构
[1] Univ KwaZulu Natal, Coll Hlth Sci, Discipline Pharmaceut Sci, Private Bag,Durban X54001, ZA-4000 Durban, South Africa
[2] United States Int Univ Africa, Sch Pharm & Hlth Sci, Dept Pharmaceut & Pharm Practice, POB 14634-00800, Nairobi 00800, Kenya
[3] Univ Khartoum, Fac Pharm, Khartoum, Sudan
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
Hybrid nanosystems; Antibacterial; Drug delivery; Bacterial infections; Antibiotic resistance; Nanocarriers; LIPID-POLYMER HYBRID; METAL-ORGANIC FRAMEWORKS; MEMBRANE-COATED NANOPARTICLES; DRUG-DELIVERY; ANTIBACTERIAL ACTIVITY; CONTROLLED-RELEASE; ANTIBIOTIC DELIVERY; IN-VITRO; HYDROGEL; CHITOSAN;
D O I
10.1016/j.jconrel.2022.09.052
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Hybrid nanoparticles (NPs) are emerging as superior alternatives to conventional nanocarriers for enhancing the delivery of antibiotics and improving their targeting at the infection site, resulting in the eradication of bacterial infections and overcoming antimicrobial resistance. They can specifically control the release of antibiotics when reaching the targeted site of infection, thus enhancing and prolonging their antimicrobial efficacy. In this review, we provide a comprehensive and an up-to-date overview of the recent advances and contributions of lipid -polymer hybrid NPs; organic-inorganic hybrid NPs; metal-organic frameworks; cell membrane-coated hybrid NPs; hybrid NP-hydrogels; and various others, that have been reported in the literature for antibacterial delivery, with emphasis on their design approaches; the nanomaterials constructed; the mechanisms of drug release; and the enhanced antibacterial efficacy of the reported hybrid nanocarriers. This review also highlights future strategies that can be used to improve the potential of hybrid nanosystems to treat bacterial infections and overcome antibiotic resistance.
引用
收藏
页码:598 / 622
页数:25
相关论文
共 50 条
  • [1] Engineering dynamic covalent bond-based nanosystems for delivery of antimicrobials against bacterial infections
    Tageldin, Abdelrahman
    Omolo, Calvin A.
    Nyandoro, Vincent O.
    Elhassan, Eman
    Kassam, Sania Z. F.
    Peters, Xylia Q.
    Govender, Thirumala
    JOURNAL OF CONTROLLED RELEASE, 2024, 371 : 237 - 257
  • [2] Nanosystems for Immune Regulation against Bacterial Infections: A Review
    Zhang, Xiaodong
    Chen, Xiaokai
    Zhao, Yanli
    ACS APPLIED NANO MATERIALS, 2022, 5 (10) : 13959 - 13971
  • [3] Functionalized nanosystems for targeted mitochondrial delivery
    Durazo, Shelley A.
    Kompella, Uday B.
    MITOCHONDRION, 2012, 12 (02) : 190 - 201
  • [4] Inorganic nanoparticle engineering against bacterial infections
    Tsikourkitoudi, Vasiliki
    Henriques-Normark, Birgitta
    Sotiriou, Georgios A.
    CURRENT OPINION IN CHEMICAL ENGINEERING, 2022, 38
  • [5] Antimicrobial Peptides against Bacterial Pathogens: Innovative Delivery Nanosystems for Pharmaceutical Applications
    Imperlini, Esther
    Massaro, Federica
    Buonocore, Francesco
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [6] Engineering silica-polymer hybrid nanosystems for dual drug and gene delivery
    Cordeiro, Rosemeyre A.
    Mendonca, Patricia, V
    Coelho, Jorge
    Faneca, Henrique
    BIOMATERIALS ADVANCES, 2022, 135
  • [7] The Use of Nanomedicine for Targeted Therapy against Bacterial Infections
    Masri, Abdulkader
    Anwar, Ayaz
    Khan, Naveed Ahmed
    Siddiqui, Ruqaiyyah
    ANTIBIOTICS-BASEL, 2019, 8 (04):
  • [8] Micro/Nanosystems for Magnetic Targeted Delivery of Bioagents
    Garello, Francesca
    Svenskaya, Yulia
    Parakhonskiy, Bogdan
    Filippi, Miriam
    PHARMACEUTICS, 2022, 14 (06)
  • [9] Exosome Engineering for Targeted and Efficient Intracellular Delivery of Bortezomib
    Zhuang, Wenzhuo
    Yuan, Shushu
    Li, Bingzong
    BLOOD, 2022, 140 : 4234 - 4235
  • [10] Engineering nanosystems for transdermal delivery of antihypertensive drugs
    Fan, Mingliang
    Liu, Wengang
    Zhao, Liangfeng
    Nie, Lirong
    Wang, Yu
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2024, 29 (03) : 265 - 279